Francis Medical Announces Close of $55 Million Series B Equity Financing

Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer, today announced the completion of the company’s $55.0 million Series B equity financing.